Search for specific inhibitors of multidrug resistance in cancer

Seminars in Cancer Biology

Volumn 8, Issue 3, 1997, Pages 171-182

  Sarkadi, Balàzs ^a   Müller, Marianna ^a  

^a National Institute of Haematology and Immunology Budapest   (Hungary)

Author keywords

Inhibitors; MDR1; MRP; Multidrug transporters; P glycoprotein

Indexed keywords

ADENOSINE TRIPHOSPHATASE; ANTINEOPLASTIC AGENT; CYCLOSPORIN A; ENZYME INHIBITOR; GLYCOPROTEIN P; MEMBRANE ENZYME; MEMBRANE PROTEIN; MONOCLONAL ANTIBODY; MULTIDRUG RESISTANCE PROTEIN; VALSPODAR; VERAPAMIL;

ANIMAL CELL; ANIMAL EXPERIMENT; CANCER CHEMOTHERAPY; CONFERENCE PAPER; CONTROLLED STUDY; DRUG EFFICACY; DRUG SAFETY; DRUG SCREENING; DRUG TRANSPORT; ENZYME ACTIVITY; MOUSE; MULTIDRUG RESISTANCE; NONHUMAN; PROTEIN EXPRESSION; PROTEIN PROCESSING;

EID: 0031158802     PISSN: 1044579X     EISSN: None     Source Type: Journal    
DOI: 10.1006/scbi.1997.0069     Document Type: Conference Paper

References (92)

1. 1. Gottesman MM, Pastan I (1988) The multidrug transporter, a double-edged sword. J Biol Chem 263:12163-12166
2. 2. Endicott JA, Ling V (1989) The biochemistry of P-glycoprotein mediated multidrug resistance. Annu Rev Biochem 58:137-171
3. 3. Gottesman MM, Pastan I (1993) Biochemistry of multidrug resistance mediated by the multidrug transporter. Annu Rev Biochem 62:385-427
4. 4. Higgins CF (1992) ABC transporters-from microorganisms to man. Annu Rev Cell Biol 8:67-113
5. 5. Broxterman HJ, Giaccone G, Lankelma J (1995) Multidrug resistance proteins and other drug transport-related resistance to natural product agents. Curr Op Oncol 7:532-540
6. 6. Safa AR (1988) Photoaffinity labeling of the multidrug resistance related P-glycoprotein with photoactive analogs of verapamil. Proc Natl Acad Sci USA 85:7187-7191
7. 7. Germann UA, Chambers TC, Ambudkar SV, Pastan I, Gottesman MM (1995) Effects of phosphorylation of P-glycoprotein on multidrug resistance. J Bioenerg Biomembr 27:53-61
8. 8. Scarborough GA (1995) Drug-stimulated ATPase activity of the human P-glycoprotein. J Bioenerg Biomembr 27:37-41
9. 9. Senior AE, Al-Shawi MK, Urbatsch IL (1995) ATP hydrolysis by multidrug resistance protein from Chinese hamster ovary cells. J Bioenerg Biomembr 27:31-36
10. 10. Cole SPC, Bhardwaj G, Gerlach JH, Mackie JE, Grant CE, Almquist KC, Stewart AJ, Kurtz EU, Duncan AMV, Deeley RG (1992) Overexpression of a novel transporter gene in a multidrug resistant human lung cancer cell line. Science 258:1650-1654
11. 11. Zaman GJR, Versantvoort CHM, Smit JJM, Eijdems EWHM, de Haas M, Smith AJ, Broxterman HJ, Mulder NH, de Vries EGE, Baas F, Borst P (1993) Analysis of the expression of MRP, the gene for a new putative transmembrane drug transporter, in human multidrug resistant lung cancer cell lines. Cancer Res 53:1747-1750
12. 12. Versantvoort CHM, Broxterman, HJ, Bagrij T, Scheper RJ, Twentyman PR (1995) Regulation by gluthatione of drug transport in multidrug resistant human lung tumour cell lines overexpressing MRP. Br J Cancer 72:82-89
13. 13. Kool M, de Haas M, Scheffer GL, Scheper RJ, van Eijk MJT, Juijn JA, Baas F, Borst P (1997) Analysis of expression of cMOAT (MRP2), MRP3, MRP4, and MRP5, homologs of the multidrug resistance-associated protein gene (MRP1), in human cancer cell lines. Cancer Res 57:3537-3547
14. 14. Cole SPC, Sparks KE, Fraser K, Loe DW, Grant CE, Wilson GM, Deeley RG (1994) Pharmacological characterization of multidrug resistant MRP-transfected human tumor cells. Cancer Res 54:5902-5910
15. 15. Jedlitschky G, Leier I, Buchholz U, Center MS, Keppler D (1994) ATP-dependent transport of glutathione S-conjugates by the multidrug resistance-associated protein. Cancer Res 54:4833-4836
16. 16. Zaman GJR, Lankelma J, van Tellingen O, Beijnen J, Dekker H, Paulusma C, Oude Elferink RPJ, Baas F, Borst P (1995) Role of glutathione in the export of compounds from cells by the multidrug-resistance-associated protein. Proc Natl Acad Sci USA 92:7690-7694
17. 17. Raderer M, Scheithauer W (1993) Clinical trials of agents that reverse multidrug resistance. Cancer 72:3553-3563
18. 18. Sikic BI, Fisher GA, Lum BL, Brophy NA, Yahanda AM, Adler KM, Halsey J (1994) Clinical reversal of multidrug resistance. Cancer Treat Res 73:149-65
19. 19. Fisher GA, Lum BL, Sikic BI (1995) The reversal of multidrug resistance. Cancer Treat Res 78:45-70
20. 20. Ford JM (1996) Experimental reversal of P-glycoprotein-mediated multidrug resistance by pharmacological chemosensitisers. Eur J Cancer 32A:991-1001
21. 21. Bates SE, Wilson WH, Fojo AT, Alvarez M, Zhan Z, Regis J, Robey R, Hose C, Monks A, Kang YK, Chabner B (1996) Clinical reversal of multidrug resistance. Stem Cells 14:56-63
22. 22. Schinkel AH, Smit JJM, van Tellingen O, Beijnen JH, Wagenaar E, van Deemter L, Mol CAAM, van der Valk MA, Robanus-Maandag EC, te Riele HPJ, Berns AJM, Borst P (1994) Disruption of the mouse mdr1a P-glycoprotein gene leads to a deficiency in the blood-brain barrier and to increased sensitivity to drugs. Cell 77:491-502
23. 23. Ueda K, Pastan I, Gottesman MM (1987) Isolation and sequence of the promoter region of the human multidrug-resistance (P-glycoprotein) gene. J Biol Chem 262:17432-17436
24. 24. Zhu Q, Center MS (1994) Cloning and sequence analysis of the promoter region of the MRP gene of HL60 cells isolated for resistance to adriamycin. Cancer Res 54:4488-4492
25. 25. Chin K-V, Ueda K, Pastan I, Gottesman MM (1992) Modulation of activity of the promoter of the human MDR1 gene by Ras and p53. Science 255:459-462
26. 26. Cucco C, Calabretta B (1996) In vitro and in vivo reversal of multidrug resistance in a human leukemia-resistant cell line by mdr1 antisense oligodeoxynucleotides. Cancer Res 56:4332-4337
27. 27. Lautier D, Canitrot Y, Deeley RG, Cole SSP (1996) Multidrug resistance mediated by the multidrug resistance protein (MRP) gene. Biochem Pharmacol 52:967-977
28. 28. Bertram J, Palfner K, Killian M, Brysch W, Schlingensiepen KH, Hiddemann W, Kneba M (1995) Reversal of multidrug resistance in vitro by phosphorothioate oligonucleotides and ribozymes. Anticancer Drugs 6:123-134
29. 29. Chambers, TC, Pohl J, Glass DB, Kuo JF (1994) Phosphorylation by protein kinase C and cyclic AMP-dependent protein kinase of synthetic peptides derived from the linker region of human P-glycoprotein. Biochem J 299:309-315
30. 30. Schinkel AH, Arceci RJ, Smit JJ, Wagenaar E, Baas F, Dolle M, Tsuruo T, Mechetner EB, Roninson IB, Borst P (1993) Binding properties of monoclonal antibodies recognizing external epitopes of the human MDR1 P-glycoprotein. Int J Cancer 55:478-484
31. 31. Almquist KC, Loe DW, Hipfner DR, Mackie JE, Cole SPC, Deeley RG (1995) Characterization of the 190 kDa multidrug resistance protein (MRP) in drug-selected and transfected human tumor cells. Cancer Res 55:102-110
32. 32. Holló Zs, Homolya L, Hegedüs T, Sarkadi B (1996) Transport properties of the multidrug resistance-associated protein (MRP) in human tumour cells. FEBS Lett 383:99-104
33. 33. Schinkel AH, Kemp S, Dolle M, Rudenko G, Wagenaar E (1993) N-glycosylation and deletion mutants of the human MDR1 P-glycoprotein. J Biol Chem 268:7474-7481
34. 34. Lis H, Sharon N (1993) Protein glycosylation. Structural and functional aspects. Eur J Biochem 218:1-27
35. 35. Germann UA, Chambers TC, Ambudkar SV, Licht T, Cardarelli CO, Pastan I, Gottesman MM (1996) Characterization of phosphorylation defective mutants of human P-glycoprotein expressed in mammalian cells. J Biol Chem 271:1708-1716
36. 36. Goodfellow HR, Sardini A, Ruetz S, Callaghan R, Gros P, McNaughton PA, Higgins CF (1996) Protein kinase C mediated phosphorylation does not regulate drug transport by the human multidrug resistance P-glycoprotein. J Biol Chem 271:13668-13674
37. 37. Ma L, Krishnamachary N, Center MS (1995) Phosphorylation of the multidrug resistance associated protein gene encoded protein P190. Biochemistry 34:3338-3343
38. 38. Stride BD, Valdimarsson G, Gerlach JH, Wilson GM, Cole SSP, Deeley RG (1996) Sructure and expression of the mRNA encoding the murine multidrug resistance protein, an ATP-binding cassette transporter. Mol Pharmacol 49:962-71
39. 39. Tsuruo T, Iida H, Tsukagoshi S, Sakurai Y (1981) Overcoming of vicristine resistance in P388 leukemia in vivo and in vitro through enhanced cytotoxicity of vincristine and vinblastine by verapamil. Cancer Res 41:1967-1972
40. 40. Tsuruo T, Iida H, Nojiri M, Tsukagoshi S, Sakurai Y (1983) Circumvention of vincristine and adriamycin resistance in vitro and in vivo by calcium influx blockers. Cancer Res 43:2905-2910
41. 41. Bates SE, Zhan Z, Dickstein B, Lee JS, Scala S, Fojo AT, Paull K, Wilson W (1994) Reversal of multidrug resistance. J Hematother 3:219-223
42. 42. Chan HSL, Grogan TM, DeBoer G, Haddad G, Gallie BL, Ling V (1996) Diagnosis and reversal of multidrug resistance in paediatric cancers. Eur J Cancer 32A:1051-61
43. 43. Hegewisch-Becker S (1996) MDR1 reversal: criteria for clinical trials designed to overcome the multidrug resistance phenotype. Leukemia 10:suppl pS32-S38
44. 44. Kuttesch JF Jr (1996) Multidrug resistance in pediatric oncology. Invest New Drugs 14:55-67
45. 45. Salmon SE, Dalton WS, Grogan TM, Plezia P, Lehnert M, Roe DJ, Miller TP (1991) Multidrug-resistant myeloma: laboratory and clinical effects of verapamil as a chemosensitizer. Blood 78:44-50
46. 46. Sonneveld P (1996) Reversal of multidrug resistance in acute myeloid leukaemia and other haematological malignancies. Eur J Cancer 32A:1062-1069
47. 47. Watanabe T, Tsuge H, Oh-Hara T, Naito M, Tsuruo T (1995) Comparative study on reversal efficacy of SDZ PSC 833, cyclosporin A and verapamil on multidrug resistance in vitro and in vivo. Acta Oncol 34:235-41
48. 48. Gruber A, Peterson C, Reizenstein P (1988) D-verapamil and L-verapamil are equally effective in increasing vincristine accumulation in leukemic cells in vitro. Int J Cancer 41:224-226
49. 49. Wilson WH, Bates SE, Fojo A, Bryant G, Zhan Z, Regis J, Wittes RE, Jaffe ES, Steinberg SM, Herdt J, et al (1995) Controlled trial of dexverapamil, a modulator of multidrug resistance, in lymphomas refractory to EPOCH chemotherapy. J Clin Oncol 13:1995-2004
50. 50. Boesch D, Muller K, Pourtier-Manzadeno A, Loor F (1991) Restoration of daunomycin retention in multidrug-resistant P388 cells by submicromolar concentrations of SDZ PSC 833, a nonimmunosuppressive cyclosporin derivative. Exp Cell Res 196:26-32
51. 51. Hyafil F, Vergely C, Du Vignaud P, Grand-Perret T (1993) In vitro and in vivo reversal of multidrug resistance by GF120918, an acridonecarboxamide derivative. Cancer Res 53:4595-4602
52. 52. den Ouden D, van den Heuvel M, Schoester M, van Rens G, Sonneveld P (1996) In vitro effect of GF120918, a novel reversal agent of multidrug resistance, on acute leukemia and multiple myeloma cells. Leukemia 10:1930-1936
53. 53. Soudon J, Berlion M, Lucas C, Haddad P, Bizzari JP, Calvo F (1995) In vitro activity of S 9788 on a multidrug-resistant leukemic cell line and on normal hematopoietic cells-reversal of multidrug resistance by sera from phase I-treated patients. Cancer Chemother Pharmacol 36:195-203
54. 54. Dantzig AH, Shepard RL, Cao J, Law KL, Ehlhardt WJ, Baughman TM, Bumol TF, Starling JJ (1996) Reversal of P-glycoprotein-mediated multidrug resistance by a potent cyclopropyldibenzosuberane modulator, LY335979. Cancer Res 56:4171-4179
55. 55. Smith CD, Prinsep MR, Caplan FR, Moore RE, Patterson GM (1994) Reversal of multiple drug resistance by tolyporphin, a novel cyanobacterial natural product. Oncol Res 6:211-218
56. 56. Broxterman HJ, Pinedo HM, Schuurhuis GJ, Lankelma J (1990) Cyclosporin A and verapamil have different effects on energy metabolism in multidrug-resistant tumour cells. Br J Cancer 62:85-88
57. 57. Cohen D (1997) Modulation of resistance and P-glycoprotein function in tumor cells. 'ATP Binding Cassette (ABC) Transporters: From multidrug Resistance to Genetic Disease', Abstract Book, p. 46
58. 58. Versantvoort CHM, Broxterman HJ, Lankelma J, Feller N, Pinedo HM (1994) Competitive inhibition by genistein and ATP dependence of daunorubicin transport in intact MRP overexpressing human small cell lung cancer cells. Biochem Pharmacol 48:1129-1136
59. 59. Zaman GJR, Flens MJ, van Leusden MR, de Haas M, Mülder HS, Lankelma J, Pinedo HM, Scheper RJ, Baas F, Broxterman HJ, Borst P (1994) The human multidrug resistance-associated protein MRP is a plasma membrane drug-efflux pump. Proc Natl Acad Sci USA 91:8822-8826
60. 60. Twentyman PR, Versantvoort CHM (1996) Experimental modulation of MRP (multidrug resistance-associated protein)-mediated resistance. Eur J Cancer 32A:1002-1009
61. 61. Al-Shawi MK, Senior AE (1993) Characterization of the adenosine triphosphatase activity of Chinese hamster P-glycoprotein. J Biol Chem 268:4197-4206
62. 62. Al-Shawi MK, Urbatsch IL, Senior AE (1994) Covalent inhibitors of P-glycoprotein ATPase activity. J Biol Chem 269:8986-8992
63. 63. Sharom FJ, Yu X, Doige CA (1993) Functional reconstitution of drug transport and ATPase activity in proteoliposomes containing partially purified P-glycoprotein. J Biol Chem 268:24197-24202
64. 64. Shapiro A, Ling V (1997) Effect of quercetin on Hoechst 33342 transport by purified and reconstituted P-glycoprotein. Biochem Pharmacol 53:587-596
65. 65. Hamada H, Tsuruo T (1986) Functional role for the 170-to 180-kDa glycoprotein specific to drug-resistant tumor cells as revealed by monoclonal antibodies. Proc Natl Acad Sci USA 83:7785-7789
66. 66. Pearson JW, Fogler WE, Volker K, Usui N, Goldenberg SK, Gruys E, Riggs CW, Komschlies K, Wiltrout RH, Tsuruo T, Pastan I, Gottesman MM, Longo DL (1991) Reversal of drug resistance in a human colon cancer xenograft expressing MDR1 complementary DNA by in vivo administration of MRK-16 monoclonal antibody. J Nat Cancer Inst 83:1386-1391
67. 67. Rittmann-Grauer LS, Yong MA, Sanders V, Mackensen DG (1992) Reversal of Vinca alkaloid resistance by anti-P-glycoprotein monoclonal antibody HYB-241 in a human tumor xenograft. Cancer Res 52:1810-1816
68. 68. Arceci RJ, Stieglitz K, Bras J, Schinkel AH, Baas F, Croop J (1993) Monoclonal antibody to an external epitope of the human mdr1 P-glycoprotein. Cancer Res 53:310-317
69. 69. Mechetner EB, Roninson IB (1992) Efficient inhibition of P-glycoprotein mediated multidrug resistance with a monoclonal antibody. Proc Natl Acad Sci USA 89:5824-5828
70. 70. Georges E, Tsuruo T, Ling V (1993) Topology of P-glycoprotein as determined by epitope mapping of MRK-16 monoclonal antibody. J Biol Chem 268:1792-1798
71. 71. Roninson IB, Schott B, Mechetner EB, Morse BS, Polonskaia M, Stein WD (1997) Mechanistic analysis of P-glycoprotein using nucleotide-binding site mutants. 'ATP Binding Cassette (ABC) Transporters: From multidrug Resistance to Genetic Disease', Abstract Book, p. 40
72. 72. FitzGerald DJ, Willingham MC, Cardarelli CO, Hamada H, Tsuruo T, Gottesman MM, Pastan I (1987) A monoclonal antibody-Pseudomonas toxin conjugate that specifically kills multidrug-resistant cells. Proc Natl Acad Sci USA 84:4288-4292
73. 73. Sarkadi B, Price EM, Boucher RC, Germann UA, Scarborough GA (1992) Expression of the human Multidrug resistance cDNA in insect cells generates a high activity drug-stimulated membrane ATPase. J Biol Chem 267:4854-4858
74. 74. Ambudkar SV (1995) Purification and reconstitution of functional human P-glycoprotein. J Bioenerg Biomembr 27:23-29
75. 75. Woodcock DM, Jefferson S, Linsenmeyer ME, Crowther PJ, Chojnowski GM, Williams B, Bertoncello I (1990) Reversal of the multidrug resistance phenotype with cremophor EL, a common vehicle for water-insoluble vitamins and drugs. Cancer Res 50:4199-203
76. 76. Roninson IB, Gudkov AV, Holzmayer TA, Kirschling DJ, Kazarov AR, Zelnick CR, Mazo IA, Axenovich S, Thimmapaya R (1995) Genetic suppressor elements: new tools for molecular oncology - thirteenth Cornelius P. Rhoads Memorial Award Lecture. Cancer Res 55:4023-4028
77. 77. Feller N, Kuiper CM, Lankelma J, Ruhdal JK, Scheper RJ, Pinedo HM, Broxterman HJ (1995) Functional detection of MDR1/P170 and MRP/P190-mediated multidrug resistance in tumour cells by flow cytometry. Br J Cancer 72:543-549
78. 78. Leith CP, Chen IM, Kopecky KJ, Appelbaum FR, Head DR, Godwin JE, Weick JK, Willman CL (1995) Correlation of multidrug resistance (MDR1) protein expression with functional dye/drug efflux in acute myeloid leukemia by multiparameter flow cytometry: identification of discordant MDR - /efflux + and MDR1 + /efflux - cases. Blood 86:2329-2342
79. 79. Twentyman PR, Rhodes T, Rayner S (1994) A comparison of rhodamine 123 accumulation and efflux in cells with P-glycoprotein-mediated and MRP-associated multidrug resistance phenotypes. Eur J Cancer 30A: 1360-1369
80. 80. Homolya L, Holló Zs, Germann UA, Pastan I, Gottesman MM, Sarkadi B (1993) Fluorescent cellular indicators are extruded by the multidrug resistance protein. J Biol Chem 268:21493-21496
81. 81. Holló Zs, Homolya L, Davis CW, Sarkadi B (1994) Calcein accumulation as a fluorometric functional assay of the multidrug transporter. Biochim Biophys Acta 1191:384-388
82. 82. Homolya L, Holló Zs, Müller M, Mechetner EB, Sarkadi B (1996) A new method for a quantitative assessment of P-glycoprotein-related multidrug resistance in tumour cells. Br J Cancer 73:849-855
83. 83. Sarkadi B, Müller M, Homolya L, Holló Zs, Seprödi J, Germann UA, Gottesman MM, Price EM, Boucher RC (1994) Interaction of bioactive hydrophobic peptides with the human multidrug transporter. FASEB J 8:766-770
84. 84. Feller N, Broxterman HJ, Währer DCR, Pinedo HM (1995) ATP-dependent efflux of calcein by the multidrug resistance protein (MRP): no inhibition by intracellular glutathione depletion. FEBS Lett 368:385-388
85. 85. Bruggemann EP, Currier SJ, Gottesman MM, Pastan I (1992) Characterization of the azidopine and vinblastine binding site of P-glycoprotein. J Biol Chem 267:21020-21026
86. 86. Liu R, Sharom FJ (1996) Site-directed fluorescence labeling of P-glycoprotein on cysteine residues in the nucleotide binding domains. Biochemistry 35:11865-11873
87. 87. Sharom FJ (1995) Characterization and functional reconstitution of the multidrug transporter. J Bioenerg Biomembr 27:15-22
88. 88. Shapiro AB, Ling V (1994) ATPase activity of purified and reconstituted P-glycoprotein from Chinese hamster ovary cells. J Biol Chem 269:3745-3754
89. 89. Doige CA, Yu X, Sharom FJ (1992) ATPase activity of partially purified P-glycoprotein from multidrug-resistant Chinese hamster ovary cells. Biochim Biophys Acta 1109:149-160
90. 90. Ambudkar SV, Lelong IH, Zhang JP, Cardarelli CO, Gottesman MM, Pastan I (1992) Partial purification and reconstitution of the human multidrug-resistance pump: characterization of the drug-stimulatable ATP hydrolysis. Proc Natl Acad Sci USA 89:8472-8476
91. 91. Sorrentino BP, Brandt SJ, Bodine D, Gottesman MM, Pastan I, Cline A, Nienhuis AW (1992) Selection of drug-resistant bone marrow cells in vivo after retroviral transfer of human MDR1. Science 257:99-103
92. 92. Lyubimov E, Lan LB, Pashinsky I, Ayesh S, Stein WD (1995) Saturation reversal of the multidrug pump using many reversers in low-dose combinations. Anticancer Drugs 6:727-735